Skip to Content

'
Adel K. El-Naggar, M.D., Ph.D.

Present Title & Affiliation

Primary Appointment

Professor, Department of Pathology, Division of Pathology/Lab Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX

Office Address

The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd.,
Unit Number: 085
Houston, TX 77030
Room Number: G1.3561A
Phone: (713) 792-3109
Fax: (713) 745-3356
Email: anaggar@mdanderson.org

Education & Training

Degree-Granting Education

1978 Department of Immunology, US Naval Research Unit-3 Ein-Shams School of Medicine, Cairo, Egypt, PHD, Mechanism of Cell-Mediated Immunity in Tuberculous Meningitis
1973 Ein-Shams School of Medicine, Cairo, Egypt, DMSc, Clinical Pathology
1970 Ein-Shams School of Medicine, Cairo, Egypt, MBChB, M.D.

Board Certifications

1988 Anatomic and Clinical Pathology

Experience/Service

Academic Appointments

Associate Professor and Pathologist, Director of Flow Cytometry Section, Department of Pathology, Pathology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX, 1991-1995
Assistant Professor, Department of Pathology, Division of Pathology/Lab Medicine, The University of Texas, M.D. Anderson Cancer Center, Houston, TX, 1987-1991

Administrative Appointments/Responsibilities

Section Chief, Department of Pathology, Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 1998-present
Head and Neck Section Chief, Cell Kinetric and Flow Cytometry, Department of Pathology, Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 1987-1998

Endowed Positions

Co-Chair of the 3rd Salivary Gland Workshop, Salivary Gland, The University of Texas MD Anderson Cancer Center, Washington, DC, 5/2012

Honors and Awards

2014 Endocrine-Related Cancer Award, Society for Endocrinology
2012-present Foreign Member of the The Royal Society of Arts and Sciences in Gothenburg, Kungl. Vetenskaps- och Vitterhets-Samhället i Göteborg
2010 The American Head and Neck Surgeons, Hayes-Martin Memorial Lectureship
2007 The American Head and Neck Surgeons, Presidential Citation
1998-present Kenneth D. Muller Endowed Professorship in Cancer Research
1997-1998 The B. Rothschild Senior Research Scholarship, Curie Institute
1994 The Mediterranean Society of Tumor Markers, Recognition Award
1978 Letter of Merits, US Naval Medical Research, Unit - 3 (NAMRU - 3)

Professional Memberships

International Head Neck Scientific Group
Member, 11/2010-present

Selected Publications

Editorials

1. El-Naggar AK, Westra WH. p16 expression as a surrogate marker for HPV-related oropharyngeal carcinoma: a guide for interpretative relevance and consistency. Head Neck 34(4):459-61, 4/2012. e-Pub 12/16/2011. PMID: 22180304.
2. Diegel CR, Cho KR, El-Naggar AK, Williams BO, Lindvall C. Mammalian target of rapamycin-dependent acinar cell neoplasia after inactivation of Apc and Pten in the mouse salivary gland: implications for human acinic cell carcinoma. Cancer Res 70(22):9143-52, 11/2010. e-Pub 11/2010. PMID: 21062985.
3. Anzick SL, Chen WD, Park Y, Meltzer P, Bell D, El-Naggar AK, Kaye FJ. Unfavorable prognosis of CRTC1-MAML2 positive mucoepidermoid tumors with CDKN2A deletions. Genes Chromosomes Cancer 49(1):59-69, 1/2010. PMCID: PMC2783528.
4. El-Naggar AK, Kaye FJ, Shirazi Y, Gutkind JS, Forastiere AA. Meeting report--the NIDCR 2(nd) Salivary Gland Tumor Meeting, November 2008. Head Neck 31(12):1542-3, 12/2009. PMID: 19890918.
5. Saintigny P, El-Naggar AK, Papadimitrakopoulou V, Ren H, Fan YH, Feng L, Lee JJ, Kim ES, Hong WK, Lippman SM, Mao L. DeltaNp63 overexpression, alone and in combination with other biomarkers, predicts the development of oral cancer in patients with leukoplakia. Clin Cancer Res 15(19):6284-91, 10/2009. e-Pub 9/2009. PMCID: PMC2756317.
6. Ramdas L, Giri U, Ashorn CL, Coombes KR, El-Naggar A, Ang KK, Story MD. miRNA expression profiles in head and neck squamous cell carcinoma and adjacent normal tissue. Head Neck. e-Pub 3/2009. PMID: 19260130.
7. El-Naggar AK, Hopper C, Upile T, Jerjes W. Head & Neck Oncology: purpose, scope and goals-charting the future. Head Neck Oncol 1:1, 2009. PMID: 19284679.
8. El-Naggar AK. Commentary: Clinicopathology features and long-term outcome of 293 phyllodes tumours of the breast. Breast Disease 19:144-145, 2008.
9. Liu Z, Hou P, Ji M, Guan H, Studeman K, Jensen K, Vasko V, El-Naggar AK, Xing M. Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase/akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancers. J Clin Endocrinol Metab 93:3106-3116, 2008. e-Pub 5/2008. PMID: 18492751.
10. El-Naggar AK. Commentary: Clear cell hidradenoma of the skin-a third tumor type with a t(11;19) associated TORC1-MAML2 gene fusion; Genes Chromosomes Cancer 2005;43:202-205. Adv Anat Pathology 13:80-82, 2006.

Last updated: 8/3/2015